A bacteriocin perspective

Bioengineered

Volumn 3, Issue 6, 2012, Pages 313-319

  Cotter, Paul D ^a,b  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bacteriocin; Bioengineering; Food grade; Food preservative; Lacticin 3147; Lantibiotic; Nisin

Indexed keywords

BACTERIOCIN; EPIDERMIN; GALLIDERMIN; LACTICIN; LANTHIOPEPTIN; LANTIBIOTIC; MERSACIDIN; MUTACIN II; NISIN; SUBTILIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; FOOD PRESERVATIVE; LACTICIN 481;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BIOENGINEERING; DRUG MECHANISM; GENE IDENTIFICATION; NONHUMAN; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; STRESS; BIOSYNTHESIS; CHEMISTRY; GENETICS; HUMAN; LACTOCOCCUS LACTIS; LISTERIA MONOCYTOGENES; METABOLISM; MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; BIOENGINEERING; FOOD PRESERVATIVES; HUMANS; LACTOCOCCUS LACTIS; LISTERIA MONOCYTOGENES; MUTAGENESIS; NISIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84868560758     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005; 3:777-88. PMID:16205711; http://dx.doi.org/10.1038/nrmicro1273.
2. Cotter PD, Emerson N, Gahan CG, Hill C. Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes. J Bacteriol 1999; 181:6840-3. PMID:10542190.
3. Cotter PD, Gahan CG, Hill C. A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid. Mol Microbiol 2001; 40:465-75. PMID:11309128; http://dx.doi.org/10.1046/j.1365-2958.2001.02398.x.
4. Liu W, Hansen JN. Enhancement of the chemical and antimicrobial properties of subtilin by sitedirected mutagenesis. J Biol Chem 1992; 267:25078-85. PMID:1460009.
5. Kuipers OP, Rollema HS, Yap WM, Boot HJ, Siezen RJ, de Vos WM. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem 1992; 267:24340-6. PMID:1447185.
6. Dodd HM, Horn N, Gasson MJ. A cassette vector for protein engineering the lantibiotic nisin. Gene 1995; 162:163-4. PMID:7557409; http://dx.doi.org/10.1016/0378-1119(95)00342-4.
7. Breukink E, van Kraaij C, Demel RA, Siezen RJ, Kuipers OP, de Kruijff B. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 1997; 36:6968-76. PMID:9188693; http://dx.doi.org/10.1021/bi970008u.
8. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999; 286:2361-4. PMID:10600751; http://dx.doi.org/10.1126/science.286.5448.2361.
9. Van Kraaij C, Breukink E, Rollema HS, Siezen RJ, Demel RA, De Kruijff B, et al. Influence of charge differences in the C-terminal part of nisin on antimicrobial activity and signaling capacity. Eur J Biochem 1997; 247:114-20. PMID:9249016; http://dx.doi.org/10.1111/j.1432-1033.1997.00114.x.
10. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 2001; 276:1772-9. PMID:11038353.
11. Ottenwälder B, Kupke T, Brecht S, Gnau V, Metzger J, Jung G, et al. Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl Environ Microbiol 1995; 61:3894-903. PMID:8526502.
12. Bierbaum G, Szekat C, Josten M, Heidrich C, Kempter C, Jung G, et al. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol 1996; 62:385-92. PMID:8593044.
13. Chen P, Novak J, Kirk M, Barnes S, Qi F, Caufield PW. Structure-activity study of the lantibiotic mutacin II from Streptococcus mutans T8 by a gene replacement strategy. Appl Environ Microbiol 1998; 64:2335-40. PMID:9647795.
14. Hindré T, Didelot S, Le Pennec JP, Haras D, Dufour A, Vallée-Réhel K. Bacteriocin detection from whole bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol 2003; 69:1051-8. PMID:12571028; http://dx.doi.org/10.1128/AEM.69.2.1051-1058.2003.
15. Szekat C, Jack RW, Skutlarek D, Färber H, Bierbaum G. Construction of an expression system for sitedirected mutagenesis of the lantibiotic mersacidin. Appl Environ Microbiol 2003; 69:3777-83. PMID:12839744; http://dx.doi.org/10.1128/AEM.69.7.3777-3783.2003.
16. Widdick DA, Dodd HM, Barraille P, White J, Stein TH, Chater KF, et al. Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc Natl Acad Sci U S A 2003; 100:4316-21. PMID:12642677; http://dx.doi.org/10.1073/pnas.0230516100.
17. Fimland G, Blingsmo OR, Sletten K, Jung G, Nes IF, Nissen-Meyer J. New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol 1996; 62:3313-8. PMID:8795220.
18. Fimland G, Eijsink VG, Nissen-Meyer J. Mutational analysis of the role of tryptophan residues in an antimicrobial peptide. Biochemistry 2002; 41:9508-15. PMID:12135373; http://dx.doi.org/10.1021/bi025856q.
19. Johnsen L, Fimland G, Eijsink V, Nissen-Meyer J. Engineering increased stability in the antimicrobial peptide pediocin PA-1. Appl Environ Microbiol 2000; 66:4798-802. PMID:11055926; http://dx.doi.org/10.1128/AEM.66.11.4798-4802.2000.
20. Johnsen L, Fimland G, Nissen-Meyer J. The C-terminal domain of pediocin-like antimicrobial peptides (class IIa bacteriocins) is involved in specific recognition of the C-terminal part of cognate immunity proteins and in determining the antimicrobial spectrum. J Biol Chem 2005; 280:9243-50. PMID:15611086; http://dx.doi.org/10.1074/jbc.M412712200.
21. Kaewsrichan J, Douglas CW, Nissen-Meyer J, Fimland G, Teanpaisan R. Characterization of a bacteriocin produced by Prevotella nigrescens ATCC 25261. Lett Appl Microbiol 2004; 39:451-8. PMID:15482437; http://dx.doi.org/10.1111/j.1472-765X.2004.01608.x.
22. Kazazic M, Nissen-Meyer J, Fimland G. Mutational analysis of the role of charged residues in target-cell binding, potency and specificity of the pediocin-like bacteriocin sakacin P. Microbiology 2002; 148:2019-27. PMID:12101290.
23. Piper C, Draper LA, Cotter PD, Ross RP, Hill C. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother 2009; 64:546-51. PMID:19561147; http://dx.doi.org/10.1093/jac/dkp221.
24. Iancu C, Grainger A, Field D, Cotter PD, Hill C, Ross RP. Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria. Probiotics Antimicrob Prot 2012.
25. Ryan MP, Jack RW, Josten M, Sahl HG, Jung G, Ross RP, et al. Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem 1999; 274:37544-50. PMID:10608807; http://dx.doi.org/10.1074/jbc.274.53.37544.
26. Skaugen M, Nissen-Meyer J, Jung G, Stevanovic S, Sletten K, Inger C, et al. In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem 1994; 269:27183-5. PMID:7961627.
27. Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, et al. A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 1996; 253:217-24. PMID:9003306; http://dx.doi.org/10.1007/s004380050315.
28. Cotter PD, Hill C, Ross RP. A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis. Appl Environ Microbiol 2003; 69:702-6. PMID:12514066; http://dx.doi.org/10.1128/AEM.69.1.702-706.2003.
29. Cotter PD, O'Connor PM, Draper LA, Lawton EM, Deegan LH, Hill C, et al. Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci U S A 2005; 102:18584-9. PMID:16339304; http://dx.doi.org/10.1073/pnas.0509371102.
30. Cotter PD, Deegan LH, Lawton EM, Draper LA, O'Connor PM, Hill C, et al. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 2006; 62:735-47. PMID:17076667; http://dx.doi.org/10.1111/j.1365-2958.2006.05398.x.
31. Deegan LH, Suda S, Lawton EM, Draper LA, Hugenholtz F, Peschel A, et al. Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol 2010; 3:222-34. PMID:21255322; http://dx.doi.org/10.1111/j.1751-7915.2009.00145.x.
32. Suda S, Hill C, Cotter PD, Ross RP. Investigating the importance of charged residues in lantibiotics. Bioeng Bugs 2010; 1:345-51. PMID:21326835; http://dx.doi.org/10.4161/bbug.1.5.12353.
33. Suda S, Westerbeek A, O'Connor PM, Ross RP, Hill C, Cotter PD. Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases. Chem Biol 2010; 17:1151-60. PMID:21035738; http://dx.doi.org/10.1016/j.chembiol.2010.08.011.
34. Field D, Collins B, Cotter PD, Hill C, Ross RP. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities. J Mol Microbiol Biotechnol 2007; 13:226-34. PMID:17827973; http://dx.doi.org/10.1159/000104747.
35. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 1996; 69:193-202. PMID:8775979; http://dx.doi.org/10.1007/BF00399424.
36. Rollema HS, Kuipers OP, Both P, de Vos WM, Siezen RJ. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Appl Environ Microbiol 1995; 61:2873-8. PMID:7487019.
37. Kuipers OP, Bierbaum G, Ottenwälder B, Dodd HM, Horn N, Metzger J, et al. Protein engineering of lantibiotics. Antonie Van Leeuwenhoek 1996; 69:161-9. PMID:8775976; http://dx.doi.org/10.1007/BF00399421.
38. Rink R, Wierenga J, Kuipers A, Kluskens LD, Driessen AJ, Kuipers OP, et al. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation. Appl Environ Microbiol 2007; 73:5809-16. PMID:17660303; http://dx.doi.org/10.1128/AEM.01104-07.
39. Field D, Hill C, Cotter PD, Ross RP. The dawning of a 'Golden era' in lantibiotic bioengineering. Mol Microbiol 2010; 78:1077-87. PMID:21091497; http://dx.doi.org/10.1111/j.1365-2958.2010.07406.x.
40. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci 2008; 65:455-76. PMID:17965835; http://dx.doi.org/10.1007/s00018-007-7171-2.
41. Yuan J, Zhang ZZ, Chen XZ, Yang W, Huan LD. Sitedirected mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl Microbiol Biotechnol 2004; 64:806-15. PMID:15048591; http://dx.doi.org/10.1007/s00253-004-1599-1.
42. Field D, Connor PM, Cotter PD, Hill C, Ross RP. The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol 2008; 69:218-30. PMID:18485077; http://dx.doi.org/10.1111/j.1365-2958.2008.06279.x.
43. Murphy K, O'Sullivan O, Rea MC, Cotter PD, Ross RP, Hill C. Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS One 2011; 6:e20852. PMID:21760885; http://dx.doi.org/10.1371/journal.pone.0020852.
44. Carroll J, Field D, O'Connor PM, Cotter PD, Coffey A, Hill C, et al. Gene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs. Bioeng Bugs 2010; 1:408-12. PMID:21468208; http://dx.doi.org/10.4161/bbug.1.6.13642.
45. Rouse S, Field D, Daly KM, O'Connor PM, Cotter PD, Hill C, et al. Bioengineered nisin derivatives with enhanced activity in complex matrices. Microb Biotechnol 2012; 5:501-8. PMID:22260415; http://dx.doi.org/10.1111/j.1751-7915.2011.00324.x.
46. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8:523-31. PMID:21844910; http://dx.doi.org/10.1038/nrgastro.2011.133.
47. Boakes S, Cortés J, Appleyard AN, Rudd BA, Dawson MJ. Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system. Mol Microbiol 2009; 72:1126-36. PMID:19400806; http://dx.doi.org/10.1111/j.1365-2958.2009.06708.x.
48. Appleyard AN, Choi S, Read DM, Lightfoot A, Boakes S, Hoffmann A, et al. Dissecting structural and functional diversity of the lantibiotic mersacidin. Chem Biol 2009; 16:490-8. PMID:19477413; http://dx.doi.org/10.1016/j.chembiol.2009.03.011.
49. Islam MR, Shioya K, Nagao J, Nishie M, Jikuya H, Zendo T, et al. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning. Mol Microbiol 2009; 72:1438-47. PMID:19432794; http://dx.doi.org/10.1111/j.1365-2958.2009.06733.x.
50. Boakes S, Ayala T, Herman M, Appleyard AN, Dawson MJ, Cortés J. Generation of an actagardine A variant library through saturation mutagenesis. Appl Microbiol Biotechnol 2012. PMID:22526797; http://dx.doi.org/10.1007/s00253-012-4041-0.
51. Kuipers OP, Rollema HS, Beerthuyzen MM, Siezen RJ, de Vos WM. Protein engineering and biosynthesis of nisin and regulation of transcription of the structural nisA gene. Int Dairy J 1995; 5:785-95; http://dx.doi.org/10.1016/0958-6946(95)00032-1.
52. Knerr PJ, van der Donk WA. Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 2012; 81:479-505. PMID:22404629; http://dx.doi.org/10.1146/annurev-biochem-060110-113521.
53. Sybesma W, Hugenholtz J, de Vos WM, Smid EJ. Safe use of genetically modified lactic acid bacteria in food. Bridging the gap between consumers, green groups, and industry. Electron J Biotechnol 2006; 9:1-25; http://dx.doi.org/10.2225/vol9-issue4-fulltext-12.